Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.

Gritstone bio (GRTS) Insider Trading & Ownership

Gritstone bio logo

Gritstone bio (NASDAQ:GRTS) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
4.61%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
3
Amount Of
Insider Selling
(Last 12 Months)
$35,453.25
Get GRTS Insider Trade Alerts

Want to know when executives and insiders are buying or selling Gritstone bio stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GRTS Insider Buying and Selling by Quarter

Gritstone bio Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/16/2024Andrew R AllenCEOSell24,263$0.75$18,197.25  
5/16/2024Erin JonesCOOSell13,749$0.75$10,311.75  
5/16/2024Matthew HawrylukEVPSell9,259$0.75$6,944.25  
(Data available from 1/1/2013 forward)

GRTS Insider Trading Activity - Frequently Asked Questions

The list of insiders at Gritstone bio includes Andrew R Allen, Erin Jones, Matthew Hawryluk, and Vassiliki Economides. Learn more on insiders at GRTS.

4.61% of Gritstone bio stock is owned by insiders. Learn more on GRTS's insider holdings.

The following insider purchased GRTS shares in the last 24 months: Vassiliki Economides ($22,800.00).

Insiders have purchased a total of 12,000 GRTS shares in the last 24 months for a total of $22,800.00 bought.

The following insiders have sold GRTS shares in the last 24 months: Andrew R Allen ($18,197.25), Erin Jones ($10,311.75), and Matthew Hawryluk ($6,944.25).

Insiders have sold a total of 47,271 Gritstone bio shares in the last 24 months for a total of $35,453.25 sold.

Gritstone bio Key Executives

  • Dr. Andrew R. Allen BCh (Age 58)
    BM, M.D., MA, MRCP, Ph.D., Co-Founder, President, CEO & Director
    Compensation: $1.01M
  • Mr. Erin E. Jones M.S. (Age 52)
    Executive VP & COO
    Compensation: $689.87k
  • Dr. Karin Jooss Ph.D. (Age 59)
    Executive VP and Head of Research & Development
    Compensation: $748.2k
  • Ms. Vassiliki Economides (Age 44)
    Executive VP & CFO
  • Mr. James Cho
    Chief Accounting Officer
  • Mr. George E. MacDougall
    Director of Investor Relations & Corporate Communications
  • Ms. Stacy Proctor
    Executive VP & Chief People Officer
  • Dr. Matthew J. Hawryluk M.B.A. (Age 46)
    Ph.D., Executive VP & Chief Business Officer


This page (NASDAQ:GRTS) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners